Point of Care Diagnostics/Testing Market Size, Share & Trends Analysis Report by Product (Glucose, Blood Gas/Electrolytes, Cancer Marker), By End Use (Clinic, Hospital), And Segment Forecasts, 2019 - 2025

Published: Mar, 2019 | Pages: 252 | Publisher: Grand View Research
Industry: Healthcare | Report Format: Electronic (PDF)

The global point of care testing market size is expected to reach USD 22.8 billion by 2025, at a CAGR of 3.3%, according to a new report by Grand View Research, Inc. The ability of Point of Care (POC) tests to render rapid and accurate results to promote patient-centered healthcare at bedside settings as well as in the remote areas results in higher penetration of POC devices and solutions.

Adaptation of automated laboratory systems and highly integrated solutions facilitate the diagnostic workflow, which in turn drives adoption of point of care diagnostic/testing products. Lack of skilled professionals or medical personnel with limited training especially in diagnostics can also easily use these devices.

Rise in R&D activities among key players to introduce novel POC tests and devices for rapid disease detection and monitoring is expected to fuel industrial progression. Recently, in February 2018, Siemens Healthineers received a Food and Drug Administration (FDA) approval for its Total Carbon Dioxide (TCO2) and Blood Urea Nitrogen (BUN) POC tests, thereby enhancing its market presence.

Moreover, high prevalence of chronic disorders and cancer results in large customer base adopting cost-effective and immediate diagnostic tests, propelling the point of care diagnostics/testing market. This is further supplemented by numerous favorable initiatives to promote the employment of POC tests in diagnosis and screening procedures.

Further key findings from the report suggest:

• Glucose testing held the maximum revenue share in 2018 due to high prevalence of diabetes and introduction of a wide variety of glucose meters by companies

• Hb1Ac testing segment is also expected to show similar trends owing to high competition among key players while delivering low-cost Hb1Ac tests

• Detection and analysis of circulating tumor cells during cancer progression is predicted to drive the cancer marker vertical with the fastest penetration rate in the forthcoming years

• Clinics is estimated to hold the dominant revenue share of the POC diagnostic industry in 2018, due to the employment of a wide range of POC tests

• Increasing awareness about decentralized tests among patients has resulted in lucrative growth of home-based POC testing

• U.S. is anticipated to North America owing to the presence of key participants with undergoing significant number of research endeavors in the country

• Continuous developments in healthcare sector to introduce novel and accurate diagnostic tests exhibit a potential growth of the market in Asia Pacific

• Major participants in the point of care diagnostics market include F. Hoffmann-La Roche Ltd.; Danaher Corporation; Abbott Laboratories; bioMerieux SA; Instrumentation Laboratory SpA; Nova Biomedical; Trividia Health, Inc.; QIAGEN; Becton Dickinson & Company; Sekisui Diagnostics LLC; Quidel Corporation; and Siemens Healthcare GmbH

• Key vendors are undergoing numerous strategic developments such as product development, acquisitions, partnerships, and agreements to gain greater market share. For instance, in May 2017, Becton, Dickinson and Company collaborated with the FIND to develop point of care based biomarker test for bacterial infections.

 Table of Contents

Chapter 1 Research Methodology & Scope
                   1.1 Market Segmentation & Scope
                   1.2 Market Definition
                   1.3 Information Procurement
                       1.3.1 Purchased database
                       1.3.2 GVR's internal database
                       1.3.3 Secondary sources & third party perspectives
                       1.3.4 Primary research
                   1.4 Information Analysis
                       1.3.1 Data analysis models
                   1.5 Market Formulation & Data Visualization
                   1.6 Data Validation & Publishing

Chapter 2 Executive Summary
                   2.1 Point of Care Diagnostics/Testing Market Outlook, 2014 - 2025
                   2.2 Point of Care Diagnostics/Testing Market : Segment Outlook, 2014 - 2025
                   2.3 Point of Care Diagnostics/Testing Market : Competitive Insights

Chapter 3 Point of Care Diagnostics/Testing Market Variables, Trends & Scope
                   3.1 Market Lineage Outlook
                       3.1.1. Parent market outlook
                       3.1.2. Related/ancillary market outlook
                   3.2 Penetration & Growth Prospect Mapping, 2018
                   3.3 Product positioning analysis
                   3.4 Price-cost-margin analysis for point-of-care devices
                   3.5 User Perspective Analysis
                       3.5.1. Consumer behavior analysis
                       3.5.2. Market influencer analysis
                   3.6 List of Key End-users By Region, By Product, By Country 
                   3.7 Technology Overview
                       3.7.1. Technology timeline
                   3.8 Regulatory Framework
                       3.8.1. Reimbursement framework
                       3.8.2. Standards & compliances
                   3.9 Point of Care Diagnostics/Testing Market - Market Dynamics
                       3.9.1 Market driver analysis
                           3.9.1.1 Introduction of CLIA waived tests
                           3.9.1.2 Increasing adoption of POC diagnostics
                           3.9.1.3 Growing demand for home healthcare and the introduction of advance technology enabled products
                           3.9.1.4 Growing geriatric population base
                           3.9.1.5 Growing prevalence of target diseases
                       3.9.2 Market restraint analysis
                           3.9.2.1 High procedure costs
                           3.9.2.2 Presence of ambiguous regulatory framework
                       3.9.3 Market challenges analysis
                           3.9.3.1 POC devices pose challenges in maintaining the quality standards 
                   3.10 Point of Care Diagnostics/Testing Market Analysis Tools
                       3.10.1 Industry Analysis - Porter's
                           3.11.1.1 Supplier power : Large scale raw material suppliers results in moderate bargaining supplier power
                           3.11.1.2 Buyer power: High bargaing power of buyer due to increased demand of POC devices
                           3.11.1.3 Substitution threat: Low substitution threat owing to the lacking replacement for POC procedures
                           3.11.1.4 New entrants threat: Low new entrant threat owing to large scale investment for POC set up
                           3.11.1.5 Competitive rivalry: High capitalization due to product launches led to high competitive rivalry
                       3.10.2 PESTEL analysis
                           3.10.2.1 Political landscape
                           3.10.2.2 Environmental landscape
                           3.10.2.3 Social landscape
                           3.10.2.4 Technology landscape
                           3.10.2.5 Legal landscape
                       3.10.3 Major deals & strategic alliances analysis
                           3.10.3.1 Joint ventures
                           3.10.3.2 Mergers & acquisitions
                           3.10.3.3 Licensing & partnership
                           3.10.3.4 Technology collaborations
                           3.10.3.5 Strategic divestments
                       3.10.4 Market entry strategies
                       3.10.5 Case studies

Chapter 4 Point of Care Diagnostics/Testing Market: Competitive Analysis
                   4.1 Recent Developments & Impact Analysis, by Key Market Participants
                   4.2 Company/Competition Categorization
                   4.3 Vendor Landscape
                       4.3.1 Key customers
                       4.3.2 Key company market share analysis, 2018
                   4.4 Public Companies
                       4.4.1 Company market position analysis
                       4.4.2 Company market share/ranking by region
                       4.4.3 Competitive dashboard analysis
                       4.4.4 Market differentiators
                       4.4.5 Synergy analysis: Major deals & strategic alliances
                   4.5 Private Companies
                       4.5.1 List of key emerging companies
                       4.5.2 Funding outlook
                       4.5.3 Regional network map
                       4.5.4 Company market position analysis
                       4.5.5 Supplier Ranking

Chapter 5 Point of Care Diagnostics/Testing Market: Product Estimates & Trend Analysis
                   5.1. Definitions & Scope
                   5.2. Product Market Share Analysis, 2018 & 2025
                   5.3 Point of Care Diagnostics/Testing Market: Product Movement Analysis, 2018 & 2025 
                   5.4. Global Point of Care Diagnostics/Testing Market, by Product, 2014 to 2025
                   5.5 Market Size & Forecasts and Trend Analyses, 2014 to 2025 for the following,
                       5.5.1 Glucose testing
                           5.5.1.1 Glucose testing market, 2014 - 2025 (USD Million)
                       5.5.2 Hb1Ac testing
                           5.5.2.1 Hb1Ac testing market, 2014 - 2025 (USD Million)
                       5.5.3 Coagulation testing
                           5.5.3.1 Coagulation testing market, 2014 - 2025 (USD Million)
                       5.5.4 Fertility testing
                           5.5.4.1 Fertility testing market, 2014 - 2025 (USD Million)
                       5.5.5 Cardiac markers
                           5.5.5.1 Cardiac markers market, 2014 - 2025 (USD Million)
                       5.5.6 Infectious disease testing
                           5.5.6.1 Infectious disease testing market, 2014 - 2025 (USD Million)
                           5.5.6.2 HIV POC testing
                               5.5.6.2.1 Global HIV POC testing market, 2014 - 2025 (USD Million)
                           5.5.6.3 Clostridium Difficile POC testing
                               5.5.6.3.1 Global Clostridium Difficile POC testing market, 2014 - 2025 (USD Million)
                           5.5.6.4 HBV POC testing
                               5.5.6.4.1 Global HBV POC testing market, 2014 - 2025 (USD Million)
                           5.5.6.5 Pneumonia or streptococcus associated infections
                               5.5.6.5.1 Global pneumonia or streptococcus associated infections market, 2014 - 2025 (USD Million)
                           5.5.6.6 Respiratory Syncytial Virus (RSV) POC testing
                               5.5.6.6.1 Global Respiratory Syncytial Virus (RSV) POC testing market, 2014 - 2025 (USD Million)
                           5.5.6.7 HPV POC testing
                               5.5.6.7.1 Global HPV POC testing market, 2014 - 2025 (USD Million)
                           5.5.6.8 Influenza/flu POC testing
                               5.5.6.8.1 Global influenza/flu POC testing market, 2014 - 2025 (USD Million)
                           5.5.6.9 HCV POC testing
                               5.5.6.9.1 Global HCV POC testing market, 2014 - 2025 (USD Million)
                           5.5.6.10 MRSA POC testing
                               5.5.6.10.1 Global MRSA POC testing market, 2014 - 2025 (USD Million)
                           5.5.6.11 TB and drug-resistant TB POC 
                               5.5.6.11.1 Global TB and drug-resistant TB POC testing market, 2014 - 2025 (USD Million)
                           5.5.6.12 HSV POC testing
                               5.5.6.12.1 Global HSV POC testing market, 2014 - 2025 (USD Million)
                           5.5.6.13 Other infectious diseases POC testing
                               5.5.6.13.1 Global other infectious diseases POC testing market, 2014 - 2025 (USD Million)
                       5.5.7 Primary care systems
                           5.5.7.1 Primary care systems market, 2014 - 2025 (USD Million)
                       5.5.8 Hematology testing
                           5.5.8.1 Hematology testing market, 2014 - 2025 (USD Million)
                       5.5.9 Decentralized clinical chemistry
                           5.5.9.1 Decentralized clinical chemistry market, 2014 - 2025 (USD Million)
                       5.5.10 Blood gas/electrolytes testing
                           5.5.10.1 Blood gas/electrolytes testing market, 2014 - 2025 (USD Million)
                       5.5.11 Ambulatory chemistry
                           5.5.11.1 Ambulatory chemistry market, 2014 - 2025 (USD Million)
                       5.5.12 Urinalysis
                           5.5.12.1 Urinanalysis market, 2014 - 2025 (USD Million)
                       5.5.13 Drug abuse testing
                           5.5.13.1 Drug abuse testing market, 2014 - 2025 (USD Million)
                       5.5.14 Thyroid stimulating hormone
                           5.5.14.1 Thyroid stimulating hormone testing market, 2014 - 2025 (USD Million)
                       5.5.15 Feces testing
                           5.5.15.1 Feces testing market, 2014 - 2025 (USD Million)
                       5.5.16 Lipid testing
                           5.5.16.1 Lipid testing market, 2014 - 2025 (USD Million)
                       5.5.17 Cancer marker testing
                           5.5.17.1 Cancer marker testing market, 2014 - 2025 (USD Million)
                   5.6 Point of Care Diagnostics/Testing Product Market, by End Use, 2014 to 2025

Chapter 6 Point of Care Diagnostics/Testing Market: End Use Estimates & Trend Analysis
                   6.1. Definitions & Scope
                   6.2. End Use Market Share Analysis, 2018 & 2025
                   6.3 Point of Care Diagnostics/Testing Market: End Use Movement Analysis, 2018 & 2025 
                   6.4. Global Point of Care Diagnostics/Testing Market, by End Use, 2014 to 2025
                   6.5 Market Size & Forecasts and Trend Analyses, 2014 to 2025 for the following,
                       6.5.1 Clinics
                           6.5.1.1 Clinics market, 2014 - 2025 (USD Million)
                           6.5.1.2 Pharmacy & retail clinics
                               6.5.1.2.1 Global pharmacy & retail clinics market, 2014 - 2025 (USD Million)
                           6.5.1.3 Phsician office
                               6.5.1.3.1 Global phsician office market, 2014 - 2025 (USD Million)
                           6.5.1.4 Urgent care clinics
                               6.5.1.4.1 Global urgent care clinics market, 2014 - 2025 (USD Million)
                           6.5.1.5 Non-practice clinics
                               6.5.1.5.1 Global non-practice clinics market, 2014 - 2025 (USD Million)
                       6.5.2 Hospitals
                           6.5.2.1 Hospitals market, 2014 - 2025 (USD Million)
                       6.5.3 Home
                           6.5.3.1 Home market, 2014 - 2025 (USD Million)
                       6.5.4 Assisted Living Healthcare Facilities
                           6.5.4.1 Assisted living healthcare facilities market, 2014 - 2025 (USD Million)
                       6.5.5 Laboratories
                           6.5.5.1 Laboratories market, 2014 - 2025 (USD Million)
                       6.5.6 Others
                           6.5.6.1 Other end use market, 2014 - 2025 (USD Million)

Chapter 7 Point of Care Diagnostics/Testing Market: Regional Estimates & Trend Analysis, by Product, & End Use
                   7.1 Point of Care Diagnostics/Testing Market Share by Region, 2018 & 2025
                   7.2 Regional Market Share and Leading Players, 2018
                       7.2.1 North America 
                       7.2.2 Europe
                       7.2.3 Asia Pacific
                       7.2.4 Latin America
                       7.2.5 Middle East & Africa
                   7.3 North America
                       7.3.1 North America point of care diagnostics/testing market, 2014 - 2025 (USD Million)
                       7.3.2 U.S.
                           7.3.2.1 U.S. point of care diagnostics/testing market, by product, 2014 - 2025 (USD Million)
                           7.3.2.2 U.S. point of care diagnostics/testing market, by end use, 2014 - 2025 (USD Million)
                       7.3.3 Canada.
                           7.3.3.1 Canada point of care diagnostics/testing market, by product, 2014 - 2025 (USD Million)
                           7.3.3.2 Canada point of care diagnostics/testing market, by end use, 2014 - 2025 (USD Million)
                   7.4 Europe
                       7.4.1 Europe point of care diagnostics/testing market, 2014 - 2025 (USD Million)
                       7.4.2 Germany
                           7.4.2.1 Germany point of care diagnostics/testing market, by product, 2014 - 2025 (USD Million)
                           7.4.2.2 Germany point of care diagnostics/testing market, by end use, 2014 - 2025 (USD Million)
                       7.4.3 France
                           7.4.3.1 France point of care diagnostics/testing market, by product, 2014 - 2025 (USD Million)
                           7.4.3.2 France point of care diagnostics/testing market, by end use, 2014 - 2025 (USD Million)
                       7.4.4 Italy
                           7.4.4.1 Italy point of care diagnostics/testing market, by product, 2014 - 2025 (USD Million)
                           7.4.4.2 Italy point of care diagnostics/testing market, by end use, 2014 - 2025 (USD Million)
                       7.4.5 Spain
                           7.4.5.1 Spain point of care diagnostics/testing market, by product, 2014 - 2025 (USD Million)
                           7.4.5.2 Spain point of care diagnostics/testing market, by end use, 2014 - 2025 (USD Million)
                       7.4.6 U.K.
                           7.4.6.1 U.K. point of care diagnostics/testing market, by product, 2014 - 2025 (USD Million)
                           7.4.6.2 U.K. point of care diagnostics/testing market, by end use, 2014 - 2025 (USD Million)
                       7.4.7 Russia
                           7.4.7.1 Russia point of care diagnostics/testing market, by product, 2014 - 2025 (USD Million)
                           7.4.7.2 Russia point of care diagnostics/testing market, by end use, 2014 - 2025 (USD Million)
                   7.5 Asia Pacific
                       7.5.1 Asia Pacific point of care diagnostics/testing market, 2014 - 2025 (USD Million)
                       7.5.2 Japan
                           7.5.2.1 Japan point of care diagnostics/testing market, by product, 2014 - 2025 (USD Million)
                           7.5.2.2 Japan point of care diagnostics/testing market, by end use, 2014 - 2025 (USD Million)
                       7.5.3 China
                           7.5.3.1 China point of care diagnostics/testing market, by product, 2014 - 2025 (USD Million)
                           7.5.3.2 China point of care diagnostics/testing market, by end use, 2014 - 2025 (USD Million)
                       7.5.4 India
                           7.5.4.1 India point of care diagnostics/testing market, by product, 2014 - 2025 (USD Million)
                           7.5.4.2 India point of care diagnostics/testing market, by end use, 2014 - 2025 (USD Million)
                       7.5.5 Australia
                           7.5.5.1 Australia point of care diagnostics/testing market, by product, 2014 - 2025 (USD Million)
                           7.5.5.2 Australia point of care diagnostics/testing market, by end use, 2014 - 2025 (USD Million)
                       7.5.6 Korea
                           7.5.6.1 Korea point of care diagnostics/testing market, by product, 2014 - 2025 (USD Million)
                           7.5.6.2 Korea point of care diagnostics/testing market, by end use, 2014 - 2025 (USD Million)
                       7.5.7 Singapore
                           7.5.7.1 Singapore point of care diagnostics/testing market, by product, 2014 - 2025 (USD Million)
                           7.5.7.2 Singapore point of care diagnostics/testing market, by end use, 2014 - 2025 (USD Million)
                   7.6 Latin America
                       7.6.1 Latin America point of care diagnostics/testing market, 2014 - 2025 (USD Million)
                       7.6.2 Brazil
                           7.6.2.1 Brazil point of care diagnostics/testing market, by product, 2014 - 2025 (USD Million)
                           7.6.2.2 Brazil point of care diagnostics/testing market, by end use, 2014 - 2025 (USD Million)
                       7.6.3 Mexico
                           7.6.3.1 Mexico point of care diagnostics/testing market, by product, 2014 - 2025 (USD Million)
                           7.6.3.2 Mexico point of care diagnostics/testing market, by end use, 2014 - 2025 (USD Million)
                       7.6.4 Argentina
                           7.6.4.1 Argentina point of care diagnostics/testing market, by product, 2014 - 2025 (USD Million)
                           7.6.4.2 Argentina point of care diagnostics/testing market, by end use, 2014 - 2025 (USD Million)
                       7.6.5 Chile
                           7.6.5.1 Chile point of care diagnostics/testing market, by product, 2014 - 2025 (USD Million)
                           7.6.5.2 Chile point of care diagnostics/testing market, by end use, 2014 - 2025 (USD Million)
                   7.7 Middle East & Africa
                       7.7.1 Middle East & Africa point of care diagnostics/testing market, 2014 - 2025 (USD Million)
                       7.7.2 South Africa.
                           7.7.2.1 South Africa point of care diagnostics/testing market, by product, 2014 - 2025 (USD Million)
                           7.7.2.2 South Africa point of care diagnostics/testing market, by end use, 2014 - 2025 (USD Million)
                       7.7.3 Kenya
                           7.7.3.1 Kenya point of care diagnostics/testing market, by product, 2014 - 2025 (USD Million)
                           7.7.3.2 Kenya point of care diagnostics/testing market, by end use, 2014 - 2025 (USD Million)
                       7.7.4 Nigeria
                           7.7.4.1 Nigeria point of care diagnostics/testing market, by product, 2014 - 2025 (USD Million)
                           7.7.4.2 Nigeria point of care diagnostics/testing market, by end use, 2014 - 2025 (USD Million)
                       7.7.5 Saudi Arabia
                           7.7.5.1 Saudi Arabia point of care diagnostics/testing market, by product, 2014 - 2025 (USD Million)
                           7.7.5.2 Saudi Arabia point of care diagnostics/testing market, by end use, 2014 - 2025 (USD Million)
                       7.7.6 Zimbabwe
                           7.7.6.1 Zimbabwe point of care diagnostics/testing market, by product, 2014 - 2025 (USD Million)
                           7.7.6.2 Zimbabwe point of care diagnostics/testing market, by end use, 2014 - 2025 (USD Million)
                       7.7.7 UAE
                           7.7.7.1 UAE point of care diagnostics/testing market, by product, 2014 - 2025 (USD Million)
                           7.7.7.2 UAE point of care diagnostics/testing market, by end use, 2014 - 2025 (USD Million)
                       7.7.8 Qatar
                           7.7.8.1 Qatar point of care diagnostics/testing market, by product, 2014 - 2025 (USD Million)
                           7.7.8.2 Qatar point of care diagnostics/testing market, by end use, 2014 - 2025 (USD Million)

Chapter 8 Competitive Landscape
                   8.1 Strategy framework
                   8.2 Market participation categorization
                   8.3 Company Profiles
                       8.3.1 F. Hoffmann-La Roche Ltd.
                           8.3.1.1 Company Overview
                           8.3.1.2 Financial Performance
                           8.3.1.3 Product Benchmarking
                           8.3.1.4 Strategic Initiatives
                       8.3.2 Abbott Laboratories
                           8.3.2.1 Company Overview
                           8.3.2.2 Financial Performance
                           8.3.2.3 Product Benchmarking
                           8.3.2.4 Strategic Initiatives
                       8.3.3 Siemens Healthcare GmBH
                           8.3.3.1 Company Overview
                           8.3.3.2 Financial Performance
                           8.3.3.3 Product Benchmarking
                           8.3.3.4 Strategic Initiatives
                       8.3.4 Danaher Corporation 
                           8.3.4.1 Company Overview
                           8.3.4.2 Financial Performance
                           8.3.4.3 Product Benchmarking
                           8.3.4.4 Strategic Initiatives
                       8.3.5 bioMerieux SA
                           8.3.5.1 Company Overview
                           8.3.5.2 Financial Performance
                           8.3.5.3 Product Benchmarking
                           8.3.5.4 Strategic Initiatives
                       8.3.6 Abaxis, Inc.
                           8.3.6.1 Company Overview
                           8.3.6.2 Financial Performance
                           8.3.6.3 Product Benchmarking
                           8.3.6.4 Strategic Initiatives
                       8.3.7 Becton Dickinson & Company
                           8.3.7.1 Company Overview
                           8.3.7.2 Financial Performance
                           8.3.7.3 Product Benchmarking
                           8.3.7.4 Strategic Initiatives
                       8.3.8 Qiagen N.V.
                           8.3.8.1 Company Overview
                           8.3.8.2 Financial Performance
                           8.3.8.3 Product Benchmarking
                           8.3.8.4 Strategic Initiatives
                       8.3.9 Spectral Diagnostics
                           8.3.9.1 Company Overview
                           8.3.9.2 Financial Performance
                           8.3.9.3 Product Benchmarking
                           8.3.9.4 Strategic Initiatives
                       8.3.10 Instrumentation Laboratory SpA
                           8.3.10.1 Company Overview
                           8.3.10.2 Financial Performance
                           8.3.10.3 Product Benchmarking
                           8.3.10.4 Strategic Initiatives
                       8.3.11 Johnson and Johnson
                           8.3.11.1 Company Overview
                           8.3.11.2 Financial Performance
                           8.3.11.3 Product Benchmarking
                           8.3.11.4 Strategic Initiatives
                       8.3.12 Nova Biomedical
                           8.3.12.1 Company Overview
                           8.3.12.2 Financial Performance
                           8.3.12.3 Product Benchmarking
                           8.3.12.4 Strategic Initiatives
                       8.3.13 Nipro Diagnostics Inc
                           8.3.13.1 Company Overview
                           8.3.13.2 Financial Performance
                           8.3.13.3 Product Benchmarking
                           8.3.13.4 Strategic Initiatives
                       8.3.14 HemoCue AB
                           8.3.14.1 Company Overview
                           8.3.14.2 Financial Performance
                           8.3.14.3 Product Benchmarking
                           8.3.14.4 Strategic Initiatives
                       8.3.15 International Technidyne Corporation (ITC)
                           8.3.15.1 Company Overview
                           8.3.15.2 Financial Performance
                           8.3.15.3 Product Benchmarking
                           8.3.15.4 Strategic Initiatives
                       8.3.16 Quidel Corporation 
                           8.3.16.1 Company Overview
                           8.3.16.2 Financial Performance
                           8.3.16.3 Product Benchmarking
                           8.3.16.4 Strategic Initiatives
                       8.3.17 Trinity Biotech PLC
                           8.3.17.1 Company Overview
                           8.3.17.2 Financial Performance
                           8.3.17.3 Product Benchmarking
                           8.3.17.4 Strategic Initiatives
                       8.3.18 Sekisui Diagnostics LLC
                           8.3.18.1 Company Overview
                           8.3.18.2 Financial Performance
                           8.3.18.3 Product Benchmarking
                           8.3.18.4 Strategic Initiatives
                       8.3.19 OraSure Technologies Inc
                           8.3.19.1 Company Overview
                           8.3.19.2 Financial Performance
                           8.3.19.3 Product Benchmarking
                           8.3.19.4 Strategic Initiatives
                   8.4 List of Companies

List of Tables

TABLE 1 Country share estimation
TABLE 2 Market driver relevance analysis (Current & future impact)
TABLE 3 Market restraint relevance analysis (Current & future impact)
TABLE 4 North America point of care diagnostics/testing market estimates and forecasts, by product, 2014 - 2025 (USD Million)
TABLE 5 North America point of care diagnostics/testing market estimates and forecasts, by end use, 2014 - 2025 (USD Million)
TABLE 6 U.S. point of care diagnostics/testing market estimates and forecasts, by product, 2014 - 2025 (USD Million)
TABLE 7 U.S. point of care diagnostics/testing market estimates and forecasts, by end use, 2014 - 2025 (USD Million)
TABLE 8 Canada point of care diagnostics/testing market estimates and forecasts, by product, 2014 - 2025 (USD Million)
TABLE 9 Canada point of care diagnostics/testing market estimates and forecasts, by end use, 2014 - 2025 (USD Million)
TABLE 10 Europe point of care diagnostics/testing market estimates and forecasts, by product, 2014 - 2025 (USD Million)
TABLE 11 Europe point of care diagnostics/testing market estimates and forecasts, by end use, 2014 - 2025 (USD Million)
TABLE 12 Germany point of care diagnostics/testing market estimates and forecasts, by product, 2014 - 2025 (USD Million)
TABLE 13 Germany point of care diagnostics/testing market estimates and forecasts, by end use, 2014 - 2025 (USD Million)
TABLE 14 U.K. point of care diagnostics/testing market estimates and forecasts, by product, 2014 - 2025 (USD Million)
TABLE 15 U.K. point of care diagnostics/testing market estimates and forecasts, by end use, 2014 - 2025 (USD Million)
TABLE 16 Spain point of care diagnostics/testing market estimates and forecasts, by product, 2014 - 2025 (USD Million)
TABLE 17 Spain point of care diagnostics/testing market estimates and forecasts, by end use, 2014 - 2025 (USD Million)
TABLE 18 Italy point of care diagnostics/testing market estimates and forecasts, by product, 2014 - 2025 (USD Million)
TABLE 19 Italy point of care diagnostics/testing market estimates and forecasts, by end use, 2014 - 2025 (USD Million)
TABLE 20 France point of care diagnostics/testing market estimates and forecasts, by product, 2014 - 2025 (USD Million)
TABLE 21 France point of care diagnostics/testing market estimates and forecasts, by end use, 2014 - 2025 (USD Million)
TABLE 22 Asia Pacific point of care diagnostics/testing market estimates and forecasts, by product, 2014 - 2025 (USD Million)
TABLE 23 Asia Pacific point of care diagnostics/testing market estimates and forecasts, by end use, 2014 - 2025 (USD Million)
TABLE 24 Japan point of care diagnostics/testing market estimates and forecasts, by product, 2014 - 2025 (USD Million)
TABLE 25 Japan point of care diagnostics/testing market estimates and forecasts, by end use, 2014 - 2025 (USD Million)
TABLE 26 China point of care diagnostics/testing market estimates and forecasts, by product, 2014 - 2025 (USD Million)
TABLE 27 China point of care diagnostics/testing market estimates and forecasts, by end use, 2014 - 2025 (USD Million)
TABLE 28 India point of care diagnostics/testing market estimates and forecasts, by product, 2014 - 2025 (USD Million)
TABLE 29 India point of care diagnostics/testing market estimates and forecasts, by end use, 2014 - 2025 (USD Million)
TABLE 30 Korea point of care diagnostics/testing market estimates and forecasts, by product, 2014 - 2025 (USD Million)
TABLE 31 Korea point of care diagnostics/testing market estimates and forecasts, by end use, 2014 - 2025 (USD Million)
TABLE 32 Australia point of care diagnostics/testing market estimates and forecasts, by product, 2014 - 2025 (USD Million)
TABLE 33 Australia point of care diagnostics/testing market estimates and forecasts, by end use, 2014 - 2025 (USD Million)
TABLE 34 Singapore point of care diagnostics/testing market estimates and forecasts, by product, 2014 - 2025 (USD Million)
TABLE 35 Singapore point of care diagnostics/testing market estimates and forecasts, by end use, 2014 - 2025 (USD Million)
TABLE 36 Latin America point of care diagnostics/testing market estimates and forecasts, by product, 2014 - 2025 (USD Million)
TABLE 37 Latin America point of care diagnostics/testing market estimates and forecasts, by end use, 2014 - 2025 (USD Million)
TABLE 38 Brazil point of care diagnostics/testing market estimates and forecasts, by product, 2014 - 2025 (USD Million)
TABLE 39 Brazil point of care diagnostics/testing market estimates and forecasts, by end use, 2014 - 2025 (USD Million)
TABLE 40 Mexico point of care diagnostics/testing market estimates and forecasts, by product, 2014 - 2025 (USD Million)
TABLE 41 Mexico point of care diagnostics/testing market estimates and forecasts, by end use, 2014 - 2025 (USD Million)
TABLE 42 Argentina point of care diagnostics/testing market estimates and forecasts, by product, 2014 - 2025 (USD Million)
TABLE 43 Argentina point of care diagnostics/testing market estimates and forecasts, by end use, 2014 - 2025 (USD Million)
TABLE 44 Chile point of care diagnostics/testing market estimates and forecasts, by product, 2014 - 2025 (USD Million)
TABLE 45 Chile point of care diagnostics/testing market estimates and forecasts, by end use, 2014 - 2025 (USD Million)
TABLE 46 MEA point of care diagnostics/testing market estimates and forecasts, by product, 2014 - 2025 (USD Million)
TABLE 47 MEA point of care diagnostics/testing market estimates and forecasts, by end use, 2014 - 2025 (USD Million)
TABLE 48 South Africa point of care diagnostics/testing market estimates and forecasts, by product, 2014 - 2025 (USD Million)
TABLE 49 South Africa point of care diagnostics/testing market estimates and forecasts, by end use, 2014 - 2025 (USD Million)
TABLE 50 Kenya point of care diagnostics/testing market estimates and forecasts, by product, 2014 - 2025 (USD Million)
TABLE 51 Kenya point of care diagnostics/testing market estimates and forecasts, by end use, 2014 - 2025 (USD Million)
TABLE 52 Nigeria point of care diagnostics/testing market estimates and forecasts, by product, 2014 - 2025 (USD Million)
TABLE 53 Nigeria point of care diagnostics/testing market estimates and forecasts, by end use, 2014 - 2025 (USD Million)
TABLE 54 Saudi Arabia point of care diagnostics/testing market estimates and forecasts, by product, 2014 - 2025 (USD Million)
TABLE 55 Saudi Arabia point of care diagnostics/testing market estimates and forecasts, by end use, 2014 - 2025 (USD Million)
TABLE 56 Zimbabwe point of care diagnostics/testing market estimates and forecasts, by product, 2014 - 2025 (USD Million)
TABLE 57 Zimbabwe point of care diagnostics/testing market estimates and forecasts, by end use, 2014 - 2025 (USD Million)
TABLE 58 UAE point of care diagnostics/testing market estimates and forecasts, by product, 2014 - 2025 (USD Million)
TABLE 59 UAE point of care diagnostics/testing market estimates and forecasts, by end use, 2014 - 2025 (USD Million)
TABLE 60 Qatar point of care diagnostics/testing market estimates and forecasts, by product, 2014 - 2025 (USD Million)
TABLE 61 Qatar point of care diagnostics/testing market estimates and forecasts, by end use, 2014 - 2025 (USD Million)

List of Figures

FIG. 1 Market research process
FIG. 2 Information procurement
FIG. 3 Primary research pattern
FIG. 4 Market research approaches
FIG. 5 Value chain based sizing & forecasting
FIG. 6 QFD modelling for market share assessment
FIG. 7 Market summary
FIG. 8 Market trends & outlook
FIG. 9 Market segmentation & scope
FIG. 10 Market driver relevance analysis (Current & future impact)
FIG. 11 Shift in POC molecular diagnostic trends
FIG. 12 Global percentage of population, by age group, 2000 and 2050
FIG. 13 Population over the age of 65 years, by region, 2010 and 2050
FIG. 14 Diabetes prevalence of top 10 countries in 2013 in the age group of 20 to 79 years (million)
FIG. 15 Current and projected prevalence of diabetes, by geography, 2013 & 2035 (% increase)
FIG. 16 Market restraint relevance analysis (Current & future impact)
FIG. 17 Penetration & growth prospect mapping for products, 2018
FIG. 18 SWOT Analysis, By Factor (political & legal, economic and technological)
FIG. 19 Porter's Five Forces Analysis
FIG. 20 Competitive landscape POC diagnostics - Major market participants
FIG. 21 POC diagnostics - product segments positioning, 2018
FIG. 22 Marketing channels
FIG. 23 Roche distribution presence
FIG. 24 Instrumentation Laboratory (Werfen Group) distribution presence
FIG. 25 Abbott Laboratories distribution network coverage
FIG. 26 Alere distribution presence
FIG. 27 Siemens Healthcare distribution presence
FIG. 28 Danaher distribution presence (Radiometer and Beckman Coulter)
FIG. 29 Point-of-care diagnostics market product outlook key takeaways
FIG. 30 Point-of-care diagnostics market: Product movement analysis
FIG. 31 Global POC glucose testingmarket, 2014 - 2025 (USD Million)
FIG. 32 Global POC Hb1Ac testing market, 2014 - 2025 (USD Million)
FIG. 33 Global POC coagulation testing market, 2014 - 2025 (USD Million)
FIG. 34 Global POC fertility market, 2014 - 2025 (USD Million)
FIG. 35 Global POC cardiac markers market, 2014 - 2025 (USD Million)
FIG. 36 Global POC infectious diseases testingmarket, 2014 - 2025 (USD Million)
FIG. 37 Global HIV POC testing market, 2014 - 2025 (USD Million)
FIG. 38 Global Clostridium difficile POC testing market, 2014 - 2025 (USD Million)
FIG. 39 Global HBV POC testing market, 2014 - 2025 (USD Million)
FIG. 40 Global pneumonia or streptococcus associated infectionsPOC testing market, 2014 - 2025 (USD Million)
FIG. 41 Global respiratory syncytial virus (RSV) POC testing market, 2014 - 2025 (USD Million)
FIG. 42 Global HPV POC testing market, 2014 - 2025 (USD Million)
FIG. 43 Global influenza/flu POC testing market, 2014 - 2025 (USD Million)
FIG. 44 Global HCVPOC testing market, 2014 - 2025 (USD Million)
FIG. 45 Global MRSA POC testing market, 2014 - 2025 (USD Million)
FIG. 46 Global TB and drug-resistant TBPOC testing market, 2014 - 2025 (USD Million)
FIG. 47 Global HSV POC testing market, 2014 - 2025 (USD Million)
FIG. 48 Global other infectious diseases POC testing market, 2014 - 2025 (USD Million)
FIG. 49 Global primary care systems (includes lipid) POC testing market, 2014 - 2025 (USD Million)
FIG. 50 Global hematology testing market, 2014 - 2025 (USD Million)
FIG. 51 Global decentralized clinical chemistry POC testing market, 2014 - 2025 (USD Million)
FIG. 52 Global feces POC testing market, 2014 - 2025 (USD Million)
FIG. 53 Global blood gas/electrolytesPOC testing market, 2014 - 2025 (USD Million)
FIG. 54 Global ambulatory chemistryPOC testing market, 2014 - 2025 (USD Million)
FIG. 55 Global urinalysis POC testing market, 2014 - 2025 (USD Million)
FIG. 56 Global drug abuse POC testing market, 2014 - 2025 (USD Million)
FIG. 57 Global thyroid stimulating hormone POC testing market, 2014 - 2025 (USD Million)
FIG. 58 Global lipid POC testing market, 2014 - 2025 (USD Million)
FIG. 59 Global cancer markers POC testing market, 2014 - 2025 (USD Million)
FIG. 60 Point-of-care diagnostics market: End use outlook key takeaways
FIG. 61 Global point-of-care diagnostics market: End use movement analysis
FIG. 62 Global primary care clinics market, 2014 - 2025 (USD Million)
FIG. 63 Global hospitals market, 2014 - 2025 (USD Million)
FIG. 64 Global home POC testing market, 2014 - 2025 (USD Million)
FIG. 65 Global assisted living healthcare facilities testingmarket, 2014 - 2025 (USD Million)
FIG. 66 Global laboratory market, 2014 - 2025 (USD Million)
FIG. 67 Regional market place: Key takeaway
FIG. 68 Point-of-care diagnosticsregional outlook, 2018 & 2025
FIG. 69 North America point of care diagnostics/testing market, 2014 - 2025 (USD Million)
FIG. 70 U.S. point of care diagnostics/testing market, 2014 - 2025 (USD Million)
FIG. 71 Canada point of care diagnostics/testing market, 2014 - 2025 (USD Million)
FIG. 72 Europe point of care diagnostics/testing market, 2014 - 2025 (USD Million)
FIG. 73 Germany point of care diagnostics/testing market, 2014 - 2025 (USD Million)
FIG. 74 France point of care diagnostics/testing market, 2014 - 2025 (USD Million)
FIG. 75 U.K. point of care diagnostics/testing market, 2014 - 2025 (USD Million)
FIG. 76 Italy point of care diagnostics/testing market, 2014 - 2025 (USD Million)
FIG. 78 Spain point of care diagnostics/testing market, 2014 - 2025 (USD Million)
FIG. 79 Asia Pacific point of care diagnostics/testing market, 2014 - 2025 (USD Million)
FIG. 80 Japan point of care diagnostics/testing market, 2014 - 2025 (USD Million)
FIG. 81 China point of care diagnostics/testing market, 2014 - 2025 (USD Million)
FIG. 82 India point of care diagnostics/testing market, 2014 - 2025 (USD Million)
FIG. 83 Korea point of care diagnostics/testing market, 2014 - 2025 (USD Million)
FIG. 84 Australia point of care diagnostics/testing market, 2014 - 2025 (USD Million)
FIG. 85 Singapore point of care diagnostics/testing market, 2014 - 2025 (USD Million)
FIG. 86 Latin America point of care diagnostics/testing market, 2014 - 2025 (USD Million)
FIG. 87 Brazil point of care diagnostics/testing market, 2014 - 2025 (USD Million)
FIG. 88 Mexico point of care diagnostics/testing market, 2014 - 2025 (USD Million)
FIG. 89 Chile point of care diagnostics/testing market, 2014 - 2025 (USD Million)
FIG. 90 Argentina POINT of care diagnostics/testing market, 2014 - 2025 (USD Million)
FIG. 91 Middle East & Africa. point-of-care diagnostics market, 2014 - 2025 (USD Million)
FIG. 92 South Africa point-of-care diagnostics market, 2014 - 2025 (USD Million)
FIG. 93 Saudi Arabia point-of-care diagnostics market, 2014 - 2025 (USD Million)
FIG. 94 UAE point-of-care diagnostics market, 2014 - 2025 (USD Million)
FIG. 95 Nigeria point-of-care diagnostics market, 2014 - 2025 (USD Million)
FIG. 96 Qatar point-of-care diagnostics market, 2014 - 2025 (USD Million)
FIG. 97 Kenya point-of-care diagnostics market, 2014 - 2025 (USD Million)
FIG. 98 Zimbabwe point-of-care diagnostics market, 2014 - 2025 (USD Million)
FIG. 99 Strategy framework
FIG. 100 Participant categorization
FIG. 101 List of companies